ID

42160

Beskrivning

Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01392898

Länk

https://clinicaltrials.gov/show/NCT01392898

Nyckelord

  1. 2016-03-13 2016-03-13 -
  2. 2021-04-13 2021-04-13 - Dr. rer. medic Philipp Neuhaus
Uppladdad den

13 april 2021

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Type 2 Diabetes Mellitus NCT01392898

Eligibility Type 2 Diabetes Mellitus NCT01392898

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with type 2 diabetes mellitus on short-term insulin therapy (≤ 12 months); all types of insulin allowed
Beskrivning

diabetes mellitus type 2; insulin therapy

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441730
UMLS CUI [2]
C0557978
documented insulin-associated weight gain ≥ 3.0 kg from the start of insulin therapy until inclusion
Beskrivning

weight gain; insulin therapy

Datatyp

boolean

Alias
UMLS CUI [1]
C0043094
UMLS CUI [2]
C0557978
age 18-75 years
Beskrivning

age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
bmi ≥ 25 kg/m2
Beskrivning

bmi

Datatyp

boolean

Alias
UMLS CUI [1]
C1305855
stable glycaemic control mirrored by hba1c ≥ 6.5 and ≤ 8.5 %
Beskrivning

hba1c

Datatyp

boolean

Alias
UMLS CUI [1]
C0019018
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
inability to provide informed consent
Beskrivning

informed consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
type 1 diabetes mellitus, mody diabetes, or lada diabetes (presence of anti-gad)
Beskrivning

Diabetes type 1; mody diabetes; lada diabetes

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441729
UMLS CUI [2]
C0342276
UMLS CUI [3]
C1960272
presence of any medical condition that might interfere with the current study protocol.
Beskrivning

Compliance behavior Limited Comorbidity

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
inflammatory bowel disease (e.g. m. crohn, ulcerative colitis)
Beskrivning

inflammatory bowel disease; Crohn Disease

Datatyp

boolean

Alias
UMLS CUI [1]
C0021390
UMLS CUI [2]
C0010346
recurrent hypoglycaemic events
Beskrivning

hypoglycaemic event recurrent

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0342312
UMLS CUI [1,2]
C2945760
diabetic gastroparesis
Beskrivning

diabetic gastroparesis

Datatyp

boolean

Alias
UMLS CUI [1]
C0267176
heart failure (lvef ≤ 30%)
Beskrivning

lvef ; heart failure

Datatyp

boolean

Alias
UMLS CUI [1]
C0428772
UMLS CUI [2]
C0018801
use of tzds (glitazones), ddp-iv (dipeptidylpeptidase-inhibitor)
Beskrivning

Thiazolidinediones

Datatyp

boolean

Alias
UMLS CUI [1]
C1257987
use of medication associated with impaired glucose metabolism including corticosteroids
Beskrivning

Adverse reaction to drug; glucose metabolism; corticosteroids

Datatyp

boolean

Alias
UMLS CUI [1]
C0041755
UMLS CUI [2]
C0596620
UMLS CUI [3]
C0001617
pregnancy or breast-feeding (contraception of at least 3 months before inclusion is required for fertile women)
Beskrivning

pregnancy; lactating

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
pre-existing thyroid disease
Beskrivning

thyroid disease

Datatyp

boolean

Alias
UMLS CUI [1]
C0040128
liver disease (aspartate aminotransferase or alanine aminotransferase level of more than three times the upper limit of normal range)
Beskrivning

liver disease; aspartate aminotransferase level; alanine aminotransferase level

Datatyp

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2,1]
C0428339
UMLS CUI [2,2]
C1272112
renal disease (creatinine > 130 µmol/l or mdrd-gfr <30 ml/min/1.73m2)
Beskrivning

renal disease; creatinine

Datatyp

boolean

Alias
UMLS CUI [1]
C0022658
UMLS CUI [2]
C0201975

Similar models

Eligibility Type 2 Diabetes Mellitus NCT01392898

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
diabetes mellitus type 2; insulin therapy
Item
patients with type 2 diabetes mellitus on short-term insulin therapy (≤ 12 months); all types of insulin allowed
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
C0557978 (UMLS CUI [2])
weight gain; insulin therapy
Item
documented insulin-associated weight gain ≥ 3.0 kg from the start of insulin therapy until inclusion
boolean
C0043094 (UMLS CUI [1])
C0557978 (UMLS CUI [2])
age
Item
age 18-75 years
boolean
C0001779 (UMLS CUI [1])
bmi
Item
bmi ≥ 25 kg/m2
boolean
C1305855 (UMLS CUI [1])
hba1c
Item
stable glycaemic control mirrored by hba1c ≥ 6.5 and ≤ 8.5 %
boolean
C0019018 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
informed consent
Item
inability to provide informed consent
boolean
C0021430 (UMLS CUI [1])
Diabetes type 1; mody diabetes; lada diabetes
Item
type 1 diabetes mellitus, mody diabetes, or lada diabetes (presence of anti-gad)
boolean
C0011849 (UMLS CUI [1,1])
C0441729 (UMLS CUI [1,2])
C0342276 (UMLS CUI [2])
C1960272 (UMLS CUI [3])
Compliance behavior Limited Comorbidity
Item
presence of any medical condition that might interfere with the current study protocol.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
inflammatory bowel disease; Crohn Disease
Item
inflammatory bowel disease (e.g. m. crohn, ulcerative colitis)
boolean
C0021390 (UMLS CUI [1])
C0010346 (UMLS CUI [2])
hypoglycaemic event recurrent
Item
recurrent hypoglycaemic events
boolean
C0342312 (UMLS CUI [1,1])
C2945760 (UMLS CUI [1,2])
diabetic gastroparesis
Item
diabetic gastroparesis
boolean
C0267176 (UMLS CUI [1])
lvef ; heart failure
Item
heart failure (lvef ≤ 30%)
boolean
C0428772 (UMLS CUI [1])
C0018801 (UMLS CUI [2])
Thiazolidinediones
Item
use of tzds (glitazones), ddp-iv (dipeptidylpeptidase-inhibitor)
boolean
C1257987 (UMLS CUI [1])
Adverse reaction to drug; glucose metabolism; corticosteroids
Item
use of medication associated with impaired glucose metabolism including corticosteroids
boolean
C0041755 (UMLS CUI [1])
C0596620 (UMLS CUI [2])
C0001617 (UMLS CUI [3])
pregnancy; lactating
Item
pregnancy or breast-feeding (contraception of at least 3 months before inclusion is required for fertile women)
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
thyroid disease
Item
pre-existing thyroid disease
boolean
C0040128 (UMLS CUI [1])
liver disease; aspartate aminotransferase level; alanine aminotransferase level
Item
liver disease (aspartate aminotransferase or alanine aminotransferase level of more than three times the upper limit of normal range)
boolean
C0023895 (UMLS CUI [1])
C0428339 (UMLS CUI [2,1])
C1272112 (UMLS CUI [2,2])
renal disease; creatinine
Item
renal disease (creatinine > 130 µmol/l or mdrd-gfr <30 ml/min/1.73m2)
boolean
C0022658 (UMLS CUI [1])
C0201975 (UMLS CUI [2])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial